446 related articles for article (PubMed ID: 26051348)
41. Lipid rafts mediate epigallocatechin-3-gallate- and green tea extract-dependent viability of human colon adenocarcinoma COLO 205 cells; clusterin affects lipid rafts-associated signaling pathways.
Pajak B; Kania E; Gajkowska B; Orzechowski A
J Physiol Pharmacol; 2011 Aug; 62(4):449-59. PubMed ID: 22100846
[TBL] [Abstract][Full Text] [Related]
42. Usage of and attitudes about green tea extract and Epigallocathechin-3-gallate (EGCG) as a therapy in individuals with Down syndrome.
Long R; Drawbaugh ML; Davis CM; Goodlett CR; Williams JR; Roper RJ
Complement Ther Med; 2019 Aug; 45():234-241. PubMed ID: 31331567
[TBL] [Abstract][Full Text] [Related]
43. Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers.
Abe O; Ono T; Sato H; Müller F; Ogata H; Miura I; Shikama Y; Yabe H; Onoue S; Fromm MF; Kimura J; Misaka S
Eur J Clin Pharmacol; 2018 Jun; 74(6):775-783. PubMed ID: 29480324
[TBL] [Abstract][Full Text] [Related]
44. Characterization of the constituents and antioxidant activity of Brazilian green tea (Camellia sinensis var. assamica IAC-259 cultivar) extracts.
Saito ST; Gosmann G; Saffi J; Presser M; Richter MF; Bergold AM
J Agric Food Chem; 2007 Nov; 55(23):9409-14. PubMed ID: 17937477
[TBL] [Abstract][Full Text] [Related]
45. Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity.
Seeram NP; Henning SM; Niu Y; Lee R; Scheuller HS; Heber D
J Agric Food Chem; 2006 Mar; 54(5):1599-603. PubMed ID: 16506807
[TBL] [Abstract][Full Text] [Related]
46. Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical Trial.
Seufferlein T; Ettrich TJ; Menzler S; Messmann H; Kleber G; Zipprich A; Frank-Gleich S; Algül H; Metter K; Odemar F; Heuer T; Hügle U; Behrens R; Berger AW; Scholl C; Schneider KL; Perkhofer L; Rohlmann F; Muche R; Stingl JC
Am J Gastroenterol; 2022 Jun; 117(6):884-894. PubMed ID: 35213393
[TBL] [Abstract][Full Text] [Related]
47. A green tea extract confection decreases circulating endotoxin and fasting glucose by improving gut barrier function but without affecting systemic inflammation: A double-blind, placebo-controlled randomized trial in healthy adults and adults with metabolic syndrome.
Zeng M; Hodges JK; Pokala A; Khalafi M; Sasaki GY; Pierson J; Cao S; Brock G; Yu Z; Zhu J; Vodovotz Y; Bruno RS
Nutr Res; 2024 Apr; 124():94-110. PubMed ID: 38430822
[TBL] [Abstract][Full Text] [Related]
48. Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities.
Elbling L; Weiss RM; Teufelhofer O; Uhl M; Knasmueller S; Schulte-Hermann R; Berger W; Micksche M
FASEB J; 2005 May; 19(7):807-9. PubMed ID: 15738004
[TBL] [Abstract][Full Text] [Related]
49. No effect of short-term green tea extract supplementation on metabolism at rest or during exercise in the fed state.
Martin BJ; Tan RB; Gillen JB; Percival ME; Gibala MJ
Int J Sport Nutr Exerc Metab; 2014 Dec; 24(6):656-64. PubMed ID: 24903465
[TBL] [Abstract][Full Text] [Related]
50. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.
Nagle DG; Ferreira D; Zhou YD
Phytochemistry; 2006 Sep; 67(17):1849-55. PubMed ID: 16876833
[TBL] [Abstract][Full Text] [Related]
51. Effects of green tea polyphenol extract and epigallocatechin-3-O-gallate on diabetes mellitus and diabetic complications: Recent advances.
Wan C; Ouyang J; Li M; Rengasamy KRR; Liu Z
Crit Rev Food Sci Nutr; 2024; 64(17):5719-5747. PubMed ID: 36533409
[TBL] [Abstract][Full Text] [Related]
52. The impact of the catechol-O-methyltransferase genotype on vascular function and blood pressure after acute green tea ingestion.
Miller RJ; Jackson KG; Dadd T; Mayes AE; Brown AL; Lovegrove JA; Minihane AM
Mol Nutr Food Res; 2012 Jun; 56(6):966-75. PubMed ID: 22707271
[TBL] [Abstract][Full Text] [Related]
53. Effect of Green Tea and (-)-Epigallocatechin Gallate on the Pharmacokinetics of Rosuvastatin.
Huang S; Xu Q; Liu L; Bian Y; Zhang S; Huang C; Miao L
Curr Drug Metab; 2020; 21(6):471-478. PubMed ID: 32407265
[TBL] [Abstract][Full Text] [Related]
54. Medicinal benefits of green tea: part II. review of anticancer properties.
Cooper R; Morré DJ; Morré DM
J Altern Complement Med; 2005 Aug; 11(4):639-52. PubMed ID: 16131288
[TBL] [Abstract][Full Text] [Related]
55. Metabolomics evaluation of the effects of green tea extract on acetaminophen-induced hepatotoxicity in mice.
Lu Y; Sun J; Petrova K; Yang X; Greenhaw J; Salminen WF; Beger RD; Schnackenberg LK
Food Chem Toxicol; 2013 Dec; 62():707-21. PubMed ID: 24080264
[TBL] [Abstract][Full Text] [Related]
56. Electron-impact and glow-discharge ionization LC-MS analysis of green tea tincture.
Venzie JL; Castro J; Balarama Krishna MV; Nelson DM; Marcus RK
Anal Bioanal Chem; 2007 Jan; 387(1):321-33. PubMed ID: 17139484
[TBL] [Abstract][Full Text] [Related]
57. Effects of green tea extract supplementation and endurance training on irisin, pro-inflammatory cytokines, and adiponectin concentrations in overweight middle-aged men.
Bagheri R; Rashidlamir A; Ashtary-Larky D; Wong A; Grubbs B; Motevalli MS; Baker JS; Laher I; Zouhal H
Eur J Appl Physiol; 2020 Apr; 120(4):915-923. PubMed ID: 32095935
[TBL] [Abstract][Full Text] [Related]
58. Chemopreventive potential of the tannase-mediated biotransformation of green tea.
Macedo JA; Ferreira LR; Camara LE; Santos JC; Gambero A; Macedo GA; Ribeiro ML
Food Chem; 2012 Jul; 133(2):358-65. PubMed ID: 25683407
[TBL] [Abstract][Full Text] [Related]
59. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome.
Basu A; Sanchez K; Leyva MJ; Wu M; Betts NM; Aston CE; Lyons TJ
J Am Coll Nutr; 2010 Feb; 29(1):31-40. PubMed ID: 20595643
[TBL] [Abstract][Full Text] [Related]
60. Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells.
Sartippour MR; Shao ZM; Heber D; Beatty P; Zhang L; Liu C; Ellis L; Liu W; Go VL; Brooks MN
J Nutr; 2002 Aug; 132(8):2307-11. PubMed ID: 12163680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
